Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostate Cancer Patients × Warfarin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 1 Prostate Cancer Patients 1 Pharmacokinetics of MDV3100 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Hematologic Neoplasms 1 Cytochrome P450 Interaction 1 Advanced Solid Tumor 1 ALK-positive Advanced Tumors 1

Interventions

repaglinide 1 Warfarin 1 Omeprazole 1 Midazolam 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04676035 2023-02-09

The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed

Prostate Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡